Delivery Order SPE2DB22D9239-SPE2DB24FDL38
Award Date
8/2/24
Potential Completion Date
8/23/24
Potential Value
$80K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $40,109.20, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a delivery order with a firm fixed price for the delivery of Keytruda 100mg/4ml, a prescription oncology medication, with a period of performance through July 8, 2024. This award is part of a larger indefinite delivery contract (IDC) held by DMS...
This federal contract award, valued at $81,895.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,567,379,133 units of Keytruda 100 mg/4 mL vial (4 mL). This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program,...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award, valued at $87,949.78, is a firm fixed-price delivery order for the supply of 4,556,888,868 units of Keytruda 100 mg/4 ml vial (4 ml). DMS Pharmaceutical Group holds a large Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables...
This federal contract award is a delivery order valued at $78,894.48, issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Keytruda 100 mg/4 ml vial, a specialized oncology medication, to support the medical needs of military healthcare facilities. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Keytruda 100 mg/4 ml vial (4 ml) to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The award, valued at $96,342.84, is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies to military health facilities. The contract, valued at up to $40,109.20, is for the delivery of Keytruda 100 mg/4 ml vial, a cancer medication, with a performance period through July 8, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with...
This federal contract award is a delivery order with a ceiling value of $77,505.20 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Keytruda 100 mg/4 ml vial, a specialized oncology medication, to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. The contract has a firm fixed-price pricing type and is not...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,947.80 firm fixed-price contract is for the supply of Keytruda 100 mg/4 ml vials to support the medical needs of military healthcare facilities. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $40,142.85, is for the delivery of Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. The contract has a completion date of June 25, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,816.60 firm fixed-price delivery order contract is for the supply of Keytruda 100 mg/4 ml vial 4 ml, a specialized oncology medication. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...